These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 16493791)

  • 1. Pharmacokinetic study of pleural fluid penetration of carbapenem antibiotic agents in chemical pleurisy.
    Niwa T; Nakamura A; Kato T; Kutsuna T; Katou K; Morita H; Kojima Y; Itoh M
    Respir Med; 2006 Feb; 100(2):324-31. PubMed ID: 16493791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Penetration of clarithromycin in experimental pleural empyema model fluid.
    Liapakis IE; Light RW; Pitiakoudis MS; Karayiannakis AJ; Giamarellos-Bourboulis EJ; Ismailos G; Anagnostoulis S; Simopoulos CE; Bouros DE
    Respiration; 2005; 72(3):296-300. PubMed ID: 15942299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacokinetic study of penetration of meropenem into pleural effusion in patients with pleurisy].
    Makino J; Yoshiyama Y; Kanke M; Kamata M; Ozawa S; Maruyama H; Shibasaki T; Masuhara K; Kobayashi T; Nakashima E
    Jpn J Antibiot; 2002 Feb; 55(1):77-88. PubMed ID: 11977923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Penetration of newer quinolones in the empyema fluid.
    Liapakis IE; Kottakis I; Tzatzarakis MN; Tsatsakis AM; Pitiakoudis MS; Ypsilantis P; Light RW; Simopoulos CE; Bouros DE
    Eur Respir J; 2004 Sep; 24(3):466-70. PubMed ID: 15358708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overview of a new carbapenem, panipenem/betamipron.
    Shimada J; Kawahara Y
    Drugs Exp Clin Res; 1994; 20(6):241-5. PubMed ID: 7758396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antibacterial activity of biapenem against recent clinical isolates].
    Hara T; Araake M; Watabe H
    Jpn J Antibiot; 2003 Apr; 56(2):138-41. PubMed ID: 12825414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Penetration of azithromycin in experimental pleural empyema fluid.
    Saroglou M; Ismailos G; Tryfon S; Liapakis I; Papalois A; Bouros D
    Eur J Pharmacol; 2010 Jan; 626(2-3):271-5. PubMed ID: 19854169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between meropenem and doripenem use density and the incidence of carbapenem-resistant Pseudomonas aeruginosa.
    Shigemi A; Matsumoto K; Yaji K; Shimodozono Y; Takeda Y; Miyanohara H; Kawamura H; Orita M; Tokuda K; Nishi J; Yamada K
    Int J Antimicrob Agents; 2009 Dec; 34(6):589-91. PubMed ID: 19748231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic-pharmacodynamic modeling and simulation for in vivo bactericidal effect in murine infection model.
    Katsube T; Yamano Y; Yano Y
    J Pharm Sci; 2008 Apr; 97(4):1606-14. PubMed ID: 17705288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bactericidal activity of biapenem against various bacteria].
    Hiraishi T; Miyata A; Hara T; Araake M; Ogawa H
    Jpn J Antibiot; 2001 Dec; 54(12):581-95. PubMed ID: 11877858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antimicrobial activities of meropenem against clinically isolated strains. The result against strains isolated from blood and cerebrospinal fluid].
    Deguchi K; Koguchi M; Suzuki Y; Tanaka S; Fukayama S; Ishihara R; Oda S; Nakane Y; Fukumoto T
    Jpn J Antibiot; 1996 Apr; 49(4):377-85. PubMed ID: 8786628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative antibacterial activity of carbapenems against P. aeruginosa (1)].
    Hikida M; Terashima S; Sato Y; Okamoato R; Inoue M
    Jpn J Antibiot; 2001 Nov; 54(11):571-9. PubMed ID: 11828603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic levels in empyemic pleural fluid.
    Teixeira LR; Sasse SA; Villarino MA; Nguyen T; Mulligan ME; Light RW
    Chest; 2000 Jun; 117(6):1734-9. PubMed ID: 10858410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Investigation on administration method of carbapenems].
    Mikamo H; Ninomiya M; Tamaya T
    Jpn J Antibiot; 2002 Dec; 55(6):875-81. PubMed ID: 12621741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimation of outer membrane permeability of carbapenem antibiotics to Pseudomonas aeruginosa.
    Iyobe S; Watanabe M; Mitsuhashi S; Inoue M
    J Infect Chemother; 1999 Sep; 5(3):168-170. PubMed ID: 11810510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison of antimicrobial use density (AUD) of carbapenem antibacterial agents and investigation of the drug susceptibility of Pseudomonas aeruginosa in 3 hospitals in southern Ibaraki Prefecture, Japan].
    Oishi T; Hitomi S; Kamoshita M; Fukue H; Kawahata D; Fukutake K
    Rinsho Byori; 2008 Jul; 56(7):570-6. PubMed ID: 18709988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [In vitro activity of biapenem (BIPM) against clinically isolated respiratory pathogens in 1996-1998].
    Watanabe A; Tokue Y; Takahashi H; Kikuchi T; Kobayashi T; Gomi K; Fujimura S; Yasui S; Nukiwa T; Shoji S; Honda Y
    Jpn J Antibiot; 1999 Dec; 52(12):690-4. PubMed ID: 10695024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antimicrobial activity of carbapenem antibiotics against gram-negative bacilli].
    Kinoshita S; Kumagai S
    Jpn J Antibiot; 1998 Sep; 51(9):551-60. PubMed ID: 9846282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Moxifloxacin pharmacokinetics and pleural fluid penetration in patients with pleural effusion.
    Chatzika K; Manika K; Kontou P; Pitsiou G; Papakosta D; Zarogoulidis K; Kioumis I
    Antimicrob Agents Chemother; 2014; 58(3):1315-9. PubMed ID: 24323477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and brain penetration of carbapenems in mice.
    Matsumoto K; Kurihara Y; Kuroda Y; Hori S; Kizu J
    J Infect Chemother; 2016 May; 22(5):346-9. PubMed ID: 26809218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.